|
Wednesday, September 15, 2010 | 5:00 PM - 7:45 PM | Glycosylation creates a range of carbohydrates or glycans, important in viruses, cancer and stem cells. Chemists and biologists collaborate to understand the analytical, synthetic and biochemical challenges of this important class of biomolecules. More
Damage to energy-producing organelles may lead to a cascade of events resulting in Alzheimer's disease. Insights into this process and the possibility of new drug targets were the topic of an Academy symposium. More
This Annals volume presents manuscripts stemming from the “4th International Conference on Oxidative/Nitrosative Stress and Disease,” held on October 28–30, 2009 at the New York Academy of Sciences. Volume 1203 More
-
Wednesday, September 15, 2010 | 5:00 PM - 7:45 PM
Speakers: Sam Danishefsky (Memorial Sloan-Kettering Cancer Center), Jon Lai (Albert Einstein College of Medicine), Lara Mahal (New York University), Suzanne Walker (Harvard Medical School) and Peng Wu (Albert Einstein College of Medicine)
Glycosylation creates a range of carbohydrates or glycans, important in viruses, cancer and stem cells. Chemists and biologists collaborate to understand the analytical, synthetic and biochemical challenges of this important class of biomolecules.
Wednesday, September 22, 2010 | 7:00 PM - 8:00 PM
Speaker: Martin Chalfie (Columbia University)
If you’ve taught middle or high school science, you’ve probably used green florescent protein (GFP). Join Nobel Laureate Dr. Martin Chalfie to discuss the discovery and development of GFP and the biological revolution it caused.
Tuesday, September 28, 2010 | 1:00 PM - 5:00 PM
Speakers: Fadi G. Akar (Mount Sinai School of Medicine), Roger J. Hajjar (Mount Sinai School of Medicine), Mariell Jessup (University of Pennsylvania College of Medicine), Walter J. Koch (Thomas Jefferson University), and Evangelia Kranias (University of Cincinnati College of Medicine)
Development of therapies to treat heart failure is hampered by a lack of understanding of underlying mechanisms. This symposium reviews current and potential therapeutic approaches, and research to identify useful molecular targets.
Monday, October 4, 2010 | 2:00 PM - 5:30 PM
Speakers: Benoît Arcangioli (Institut Pasteur), Uttiya Basu (Columbia University Medical Center), Steve Brill (Rutgers University), Scott Keeney (Memorial Sloan-Kettering Cancer Center) and Hannah Klein (NYU School of Medicine)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.
October 29 - 30, 2010
Organizers: Barry Lester (Warren Alpert Medical School of Brown University), Edward Tronick (University Massachusetts Boston and Children's Hospital Boston), and Eric Nestler (Mount Sinai School of Medicine)
This 2-day CME- and CE-accredited conference will focus on the quest to understand how environmental factors affect behavioral outcomes (learning, memory, mental illness, normal development and developmental psychopathology) via epigenetic modulation.
Tuesday, June 15, 2010 | 5:00 PM - 7:00 PM
Speakers: Benjamin Bottner (Cold Spring Harbor Laboratory), Rodrigo Fernandez-Gonzalez (Sloan Kettering Institute), Ah-Ram Kim (SUNY Stonybrook) and Andrew Tomlinson (Columbia University)
The New York Area Drosophila Discussion Group meetings includes four presentations by graduate students and post-docs selected from area laboratories by the program committee, with an emphasis on new and emerging data.
Tuesday, June 8, 2010 | 4:00 PM - 6:30 PM
Keynote Speaker: Bill Jorgensen (Yale University)
The Chemical Biology Discussion Group brings together chemists and biologists interested in learning about the latest ideas in this rapidly growing field, and provides a forum for lively discussion and collaborations between chemists and biologists.
Monday, June 7, 2010 | 2:00 PM - 7:00 PM
Keynote Speaker: Richard D. Kolodner (Ludwig Institute for Cancer Research, University of California San Diego)
The Genome Integrity Discussion Group presents meetings featuring talks by graduate students, post-docs, or laboratory heads from the tri-state area with an emphasis on new and emerging data in the area of chromosome biology and function.
May 19 - 21, 2010 | Spain
Keynote Speaker: J. Michael Bishop (The G.W. Hooper Research Foundation, University of California, San Francisco)
This conference will discuss advancements, challenges, and future steps in research leading to an individualized understanding of cancer and its translation into personalized clinical care.
|
-
Annals
Edited by Debra Laskin (Rutgers University, Department of Pharmacology and Toxicology, Piscataway, New Jersey)
This Annals volume presents manuscripts stemming from the “4th International Conference on Oxidative/Nitrosative Stress and Disease,” held on October 28–30, 2009 at the New York Academy of Sciences.
Volume 1203
Annals
Edited by Yau-Huei Wei (Mackay Medical College, Taipei County, Taiwan), Chii-Ruey Tzeng (Taipei Medical University, Taipei City, Taiwan), and Horng-Mo Lee (Central Taiwan University of Science and Technology, Taichung City, Taiwan).
This Annals volume presents manuscripts stemming from the 6th Conference of the Asian Society for Mitochondrial Research and Medicine, entitled “Mitochondrial Research in Translational Medicine,” held on October 30 to November 1, 2009 at Taipei Medical University, Taipei, Taiwan.
Volume 1201
eBriefing
Organizers: Howard Fillit (Alzheimer's Drug Discovery Foundation) and Sonya Dougal (The New York Academy of Sciences)
Damage to energy-producing organelles may lead to a cascade of events resulting in Alzheimer's disease. Insights into this process and the possibility of new drug targets were the topic of an Academy symposium.
eBriefing
Speakers: William R. Jacobs, Jr. (Albert Einstein College of Medicine), Christopher Sassetti (University of Massachusetts Medical School), Dirk Schnappinger (Weill Cornell Medical College), Helena Boshoff (NIH), and Carl Nathan (Weill Cornell Medical College)
Organizers: Takushi Kaneko (TB Alliance) and Jennifer Henry (New York Academy of Sciences)
TB kills nearly 2 million people yearly, and now shows drug resistance. This symposium highlighted how the genetic information of the pathogen and genetic tools are used in the quest for new TB drugs.
eBriefing
Speakers: John Hambor (Cell Therapy Group), Matthias Stadtfeld (Massachusetts General Hospital), Sheng Ding (Scripps Research Institute), and Timothy Kamp (University of Wisconsin) Organizers: Huiping Jiang and Katalin Kauser (Boehringer Ingelheim Pharmaceuticals)
Stem cells may be more physiologically relevant in drug discovery studies than laboratory cell lines. The cells can differentiate into mixed cell types that resemble tissues. This symposium focused on how stem cells can facilitate the development of new drugs and therapies.
Webinar Archive
February 23, 2010
Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.
Webinar Archive
October 27, 2009
What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.
Webinar Archive
April 28, 2009
Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.
|
|
|